1. 338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6). (10th December 2020) Authors: Udyavar, Akshata; Cecchini, Michael; DiRenzo, Daniel; Cho, Sean; Seitz, Lisa; Zhang, Kristen; Young, Stephen; Anderson, Amy; Gerrick, Kimberline; Walters, Matthew; Gilbert, Houston; Gardner, Olivia; Quah, Cheng; Jaen, Juan; Grossman, William Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6). (9th November 2020) Authors: Udyavar, Akshata; Cecchini, Michael; DiRenzo, Daniel; Cho, Sean; Seitz, Lisa; Zhang, Kristen; Young, Stephen; Anderson, Amy; Gerrick, Kimberline; Walters, Matthew; Gilbert, Houston; Gardner, Olivia; Quah, Cheng; Jaen, Juan; Grossman, William Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer. (10th December 2020) Authors: Paprcka, Susan; Udyavar, Akshata; Sridhar, Subhasree; Miles, Dillon; Chen, Yu; Cho, Sean; Foley, Corinne; Grange, Rebecca; Leleti, Manmohan; Zhao, Sharon; Jin, Lixia; Young, Stephen; Powers, Jay; Walters, Matthew Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 583 Novel, potent, and selective inhibitors of hypoxia-inducible factor (HIF)-2α reverse pro-tumorigenic transcriptional programming in cancer, stromal, and immune cells. (10th December 2020) Authors: Gauthier, Kelsey Sivick; Piovesan, Dana; Lawson, Kenneth; Cho, Soonweng; Udyavar, Akshata; Chan, Jean; Chen, Ada; Au, Jennie; Meleza, Cesar; Zhao, Xiaoning; Tran, Anh; Drew, Samuel; Gal, Balint; Rosen, Brandon; Leleti, Manmohan; Ginn, Elaine; Jin, Lixia; Young, Stephen; Powers, Jay; Walters, Matthew Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 583 Novel, potent, and selective inhibitors of hypoxia-inducible factor (HIF)-2α reverse pro-tumorigenic transcriptional programming in cancer, stromal, and immune cells. (9th November 2020) Authors: Gauthier, Kelsey Sivick; Piovesan, Dana; Lawson, Kenneth; Cho, Soonweng; Udyavar, Akshata; Chan, Jean; Chen, Ada; Au, Jennie; Meleza, Cesar; Zhao, Xiaoning; Tran, Anh; Drew, Samuel; Gal, Balint; Rosen, Brandon; Leleti, Manmohan; Ginn, Elaine; Jin, Lixia; Young, Stephen; Powers, Jay; Walters, Matthew Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Antiplatelet therapy following ischaemic stroke – Continue or change pre-existing therapy?. (March 2017) Authors: Mazlan-Kepli, Wardati; MacIsaac, Rachael L; Walters, Matthew; Bath, Philip MW; Dawson, Jesse Journal: European stroke journal Issue: Volume 2:Number 1(2017) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients. Issue 7 (18th August 2020) Authors: Willeit, Peter; Tschiderer, Lena; Allara, Elias; Reuber, Kathrin; Seekircher, Lisa; Gao, Lu; Liao, Ximing; Lonn, Eva; Gerstein, Hertzel C.; Yusuf, Salim; Brouwers, Frank P.; Asselbergs, Folkert W.; van Gilst, Wiek; Anderssen, Sigmund A.; Grobbee, Diederick E.; Kastelein, John J.P.; Visseren, Fran... Journal: Circulation Issue: Volume 142:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome. Issue 1 (20th July 2018) Authors: Mazlan-Kepli, Wardati; Dawson, Jesse; Berry, Colin; Walters, Matthew Journal: Heart Issue: Volume 105:Issue 1(2019) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Characteristics and treatment outcomes of newly diagnosed epilepsy in older people: A 30‐year longitudinal cohort study. (23rd October 2020) Authors: Alsfouk, Bshra Ali A.; Hakeem, Haris; Chen, Zhibin; Walters, Matthew; Brodie, Martin J.; Kwan, Patrick Journal: Epilepsia Issue: Volume 61:issue 12(2020) Page Start: 2720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90). Issue 7 (4th March 2011) Authors: Stewart, Kirsty; Walters, Matthew; Dawson, Jesse Journal: Heart Issue: Volume 97:Issue 7(2011) Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗